Independent Director · Xeris Biopharma Holdings, Inc. (XERS)

Jeffrey Sherman director compensation at Xeris Biopharma: $286K

Fiscal year 2025 director compensation for Jeffrey Sherman at Xeris Biopharma Holdings, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 23, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Jeffrey Sherman’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Jeffrey Sherman and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Xeris Biopharma Director Compensation Table · all 4 fiscal years held
In US dollars, as Xeris Biopharma reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$64,000$221,500$0$0$285,500
FY2024$62,500$121,500——$184,000
FY2022$52,500$31,500$35,735—$119,735
FY2021$45,000—$28,072—$73,072

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Xeris Biopharma Holdings, Inc. DEF 14A filed April 23, 2026, accession 0001867096-26-000021, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Xeris Biopharma Holdings, Inc. filed document, accession 0001867096-26-000021. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.

Get the Xeris Biopharma Board Governance Report

$285,500 Jeffrey Sherman, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 23, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Xeris Biopharma pays directors a $50,000 cash retainer and $300,000 in RSUs.

Committees

FY2025 · as the proxy prints them

Compensation · Nominating/Governance

The rest of the Xeris Biopharma board

FY2025 · as the company reported each
DirectorRoleFY2025 total
BJ BormannIndependent Director$294,500
Dawn HalkuffIndependent Director$290,500
Garheng KongIndependent Director$281,500
James BradyIndependent Director$606,984
John JohnsonIndependent Director$276,500
John ShannonDirector—
Marla PerskyChair of the Board$326,500

The full Xeris Biopharma compensation record

free company brief

This page is one director within Xeris Biopharma's record. The company brief lists every named executive and director, each linking to their own page.

Order XERS

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report